Josep Borrell, High Representative of the European Union for Foreign Affairs and Security Policy hopes that the EU will certify the Russian Sputnik V COVID-19 vaccine.

He added: "That would be good news because we're facing shortages of vaccines" in the EU," Euronews reported.

The scientific journal Lancet on Tuesday published the results of the third phase of Sputnik V clinical research, confirming its high efficiency and safety. During phase III clinical trials, Sputnik V demonstrated high rates of efficacy, immunogenicity, and safety - the vaccine efficacy was 91.6%. The vaccine provides complete protection against COVID-19 severe cases.